CAZZANIGA MARINA ELENA

Malighetti, F., Villa, M., Villa, A., Pelucchi, S., Aroldi, A., Cortinovis, D., et al. (2025). Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26(5) [10.3390/ijms26051943]. Detail

Cazzaniga, M., Pronzato, P., Amoroso, D., Bernardo, A., Biganzoli, L., Bisagni, G., et al. (2024). Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study. CANCERS, 16(1) [10.3390/cancers16010117]. Detail

Generali, D., Berardi, R., Caruso, M., Cazzaniga, M., Garrone, O., Minchella, I., et al. (2024). Corrigendum: Aromatase inhibitors: the journey from the state of the art to clinical open questions(Front. Oncol., (2023), 13, (1249160), 10.3389/fonc.2023.1249160) [Altro] [10.3389/fonc.2024.1369562]. Detail

Boos, J., van der Made, C., Ramakrishnan, G., Coughlan, E., Asselta, R., Loscher, B., et al. (2024). Stratified analyses refine association between TLR7 rare variants and severe COVID-19. HGG ADVANCES, 5(4) [10.1016/j.xhgg.2024.100323]. Detail

Ilari, A., Cogliati, V., Sherif, N., Grassilli, E., Ramazzotti, D., Cordani, N., et al. (2024). Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer. BIOMEDICINES, 12(2) [10.3390/biomedicines12020272]. Detail